Top Markets
Coin of the day
Dali Pharmaceuticalco.,Ltd Dali Pharmaceuticalco.,Ltd

Dali Pharmaceuticalco.,Ltd

603963
Rang in aandelen #27020
Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the... Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the research, development, manufacturing, and distribution of medicinal products. The company specializes in injectable medications, offering a diverse portfolio of both traditional Chinese and Western formulations. This includes 20 distinct drug varieties, with a total of 44 approved specifications. Key examples from their product line are Xingnaojing, Shenmai, Astragalus, Leucocin A, and Citicoline injections. Dali Pharmaceutical also maintains a substantial intellectual property collection, holding 31 patents comprised of 11 invention patents, 16 utility models, and 3 design patents. Established in 1996, the company operates from its headquarters located in Dali, China.
Aandeelprijs
$0.16240909
Laatst gesynchroniseerd: 2025-03-04
Marktkapitalisatie
$35.68M
Verandering (1 dag)
0.27%
Verandering (1 jaar)
0.00%
Land
CN
Handel Dali Pharmaceuticalco.,Ltd (603963)

Categorie

P/S-ratio voor Dali Pharmaceuticalco.,Ltd (603963)
P/S-ratio op August 2026 TTM: 2.97
Volgens de meest recente financiële rapporten en aandelenkoers van Dali Pharmaceuticalco.,Ltd is de huidige P/S-ratio (TTM) 2.97. Eind 2022 had het bedrijf een P/S-ratio van 21.68.
P/S-ratiohistoriek voor Dali Pharmaceuticalco.,Ltd van 2012 tot 2026
P/S-ratio aan het einde van elk jaar
Jaar P/S-ratio Wijzigen
2026 (TTM) 2.97 -90.20%
2023 30.30 39.75%
2022 21.68 91.44%
2021 11.32 41.15%
2020 8.02 23.66%
2019 6.49 60.68%
2018 4.04 -47.25%
2017 7.66 55.55%
2016 4.92 16.41%
2015 4.23 57.93%
2014 2.68 -12.09%
2013 3.04 -4.22%
2012 3.18 0.00%
P/S-ratio voor vergelijkbare bedrijven of concurrenten